CELLIVERY
PR
PRESS RELEASE
31
2020-01
셀리버리, "췌장암 신약후보물질 iCP-SOCS3 미국 특허 획득"
http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2020013110300111899
